RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT01490086 · COMPLETED
Trial details
- NCT number
- NCT01490086
- Sponsor
- Reviva Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-03-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.